Induction of Acute Skeletal Muscle Regeneration by Cardiotoxin Injection
January 1st, 2017
22.6K views
This manuscript describes a detailed protocol to induce acute skeletal muscle regeneration in adult mice and subsequent manipulations of the muscles, such as dissection, freezing, cutting, routine staining, and myofiber cross-sectional area analysis.
Overview
This manuscript describes a detailed protocol to induce acute skeletal muscle regeneration in adult mice and study the regeneration process in vivo. The procedure includes muscle manipulations such as dissection, freezing, cutting, and myofiber cross-sectional area analysis.
Key Study Components
Area of Science
- Neuroscience
- Regenerative Biology
- Muscle Physiology
Background
- Mouse models of muscle acute injury are effective for studying regeneration.
- The technique allows for high reproducibility of experimental steps.
- Understanding muscle regeneration can provide insights into therapeutic strategies.
- Acute injury models help investigate early to late stages of muscle healing.
Purpose of Study
- To establish a protocol for inducing muscle injury in mice.
- To analyze the regeneration process following acute injury.
- To facilitate further research into muscle repair mechanisms.
Methods Used
- Application of 70% ethanol to the hind limb of an anesthetized mouse.
- Hair removal at the anterior part of the lower leg for muscle visualization.
- Injection of cardiotoxin solution into the tibialis anterior muscle.
- Subsequent muscle dissection and analysis of myofiber cross-sectional area.
Main Results
- Successful induction of acute muscle injury in the mouse model.
- Detailed analysis of muscle regeneration stages observed.
- High reproducibility of the protocol confirmed across multiple trials.
- Insights gained into the cellular and molecular mechanisms of muscle healing.
Conclusions
- The protocol provides a reliable method for studying muscle regeneration.
- Findings contribute to the understanding of muscle repair processes.
- This model can be utilized for future research in regenerative medicine.
Frequently Asked Questions
What is the main goal of this study?
The main goal is to establish a mouse model for studying acute skeletal muscle injury and regeneration.
How is the muscle injury induced?
Muscle injury is induced by injecting a cardiotoxin solution into the tibialis anterior muscle.
What are the key methods used in this protocol?
Key methods include ethanol application, hair removal, cardiotoxin injection, and muscle analysis.
What are the expected outcomes of this study?
Expected outcomes include insights into muscle regeneration stages and mechanisms.
How reproducible is the protocol?
The protocol has shown high reproducibility across multiple trials.
What significance does this research hold?
This research is significant for advancing understanding of muscle repair and potential therapeutic strategies.
Executive Industry Relevance
This protocol establishes a reproducible in vivo model for acute skeletal muscle injury, enabling mechanistic studies of regeneration pathways critical for target validation in neuromuscular disease programs. By providing quantitative histological readouts such as myofiber size and cross-sectional area distribution, it supports predictive confidence in preclinical screening and lead identification efforts. The model facilitates translational continuity from discovery through preclinical validation, aiding in risk-adjusted advancement decisions for regenerative therapies.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by inducing controlled, reproducible muscle injury to study regeneration dynamics.
- Operational Value: Provides a standardized system for functional target validation and pathway clarification in muscle repair mechanisms.
Screening & Assay Development
- Scientific Value: Generates validated biological tissue sections suitable for downstream histological and immunofluorescence assays.
- Operational Value: Ensures assay readiness through consistent tissue preparation, sectioning, and staining protocols.
Translational & Preclinical Research
- Scientific Value: Supports disease-relevant system modeling for studying degeneration and regeneration processes in muscular dystrophies and trauma.
- Operational Value: Facilitates preclinical continuity by enabling longitudinal analysis of repair stages from early inflammation to mature myofiber formation.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from target validation through preclinical evaluation, supporting hypothesis-driven research in muscle physiology and regenerative medicine.
- Discovery Biology: Enables hypothesis testing of regeneration pathways and biological de-risking of targets involved in muscle repair.
- Screening: Delivers reproducible tissue sections with quantifiable morphometric outputs for compound or genetic modifier evaluation.
- Analytics: Provides myofiber cross-sectional area and centrally nucleated fiber measurements as quantitative endpoints for condition comparison.
- Translational Research: Connects early discovery to preclinical validation through staged histological analysis of regeneration progression.
- Enterprise Reuse: Establishes a reusable platform for studying multiple injury models and therapeutic interventions in skeletal muscle.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence in target validation by reducing mechanistic ambiguity in muscle regeneration pathways.
- Operational Value: Ensures reproducibility and standardization across laboratories, supporting cross-functional collaboration.
- Strategic Value: Improves go/no-go decisions by providing reliable preclinical data on repair mechanisms, reducing late-stage biological risk.
- Portfolio Impact: Enables risk-adjusted prioritization of regenerative candidates based on validated disease-relevant system performance.
Implementation Considerations
- Requires expertise in rodent surgery, tissue handling, and histological processing.
- Dependent on cryostat, microtome, and staining infrastructure for section preparation and analysis.
- Necessitates standardization of injection depth, muscle orientation, and section thickness across users.
- Adaptation considerations include alternative injury models (e.g., notexin, barium chloride) and different mouse strains or muscle groups.
- Practical limitations include variability in injury extent if injection technique is not standardized and the terminal nature of the model requiring endpoint analysis.
Biopharma FAQs
Why does histological analysis of myofiber size matter for target validation?
Quantitative measurement of centrally nucleated myofiber size enables assessment of regeneration progression and therapeutic efficacy in preclinical models. This metric provides a reproducible endpoint to compare conditions and supports mechanistic de-risking of targets involved in muscle repair. It allows teams to evaluate whether interventions promote timely and complete myofiber maturation.
How does isolation of the tibialis anterior tendon fit into the discovery pipeline?
Proper tendon isolation ensures intact muscle excision and orientation, which is critical for consistent sectioning and reliable histological analysis. This step supports assay standardization by minimizing variability in tissue preparation across experiments. It enables downstream applications such as immunofluorescence and morphometric analysis with high reproducibility.
What do quantitative dependent variable measurements like cross-sectional area distribution enable?
Myofiber cross-sectional area distribution at multiple time points allows tracking of regeneration stages from necrosis to mature fiber formation. These measurements provide objective, quantifiable outputs for comparing experimental groups and assessing compound effects. They support data-driven decision-making in lead identification and preclinical candidate selection.
Why do replication requirements matter for cross-functional collaboration in this model?
High reproducibility of the protocol ensures consistent injury induction and regeneration kinetics across laboratories and teams. This reliability enables confident data sharing between discovery, preclinical, and translational groups. It reduces variability that could confound target validation or lead optimization efforts.
What statistical analysis capabilities are required before implementing this model in screening workflows?
The ability to analyze myofiber size and distribution data using appropriate statistical tests is essential for detecting significant differences between conditions. This includes comparing group means and distributions across time points to evaluate regeneration dynamics. Such capabilities ensure that observed effects are robust and suitable for go/no-go decisions in therapeutic development.
Chapters in this video
0:05
Title
0:35
Cardiotoxin Injection in the Tibialis Anterior Muscle
1:29
Tibialis Anterior Isolation
2:51
Fresh Frozen Muscle Technique
4:03
Cryostat Sectioning of Frozen Muscles
4:46
Hematoxylin & Eosin Stains
5:57
Results: Time Course Analysis of Skeletal Muscle Regeneration
7:04
Conclusion
